[1] |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2):115-132.
|
[2] |
李席如,马冰,王建东,等. 乳腺癌保留乳房手术187例的临床回顾分析[J]. 中华肿瘤防治杂志,2008, 15(21):1658-1660.
|
[3] |
Litière S, Werutsky G, Fentiman IS, et al. Breast conserving therapy versus mastectomy for stage Ⅰ-Ⅱ breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial [J]. Lancet Oncol, 2012, 13(4):412-419.
|
[4] |
Clarke M, Collins R, Darby S, et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials[J]. Lancet, 2005, 366(9503):2087-2106.
|
[5] |
Mussari S, Sabino Della Sala W, Busana L, et al. Full-dose intraoperative radiotherapy with electrons in breast cancer. First report on late toxicity and cosmetic results from a single-institution experience [J]. Strahlenther Onkol, 2006, 182(10):589-595.
|
[6] |
Barber JB, Burrill W, Spreadborough AR, et al. Relationship between in vitro chromosomal radiosensitivity of peripheral blood lymphocytes and the expression of normal tissue damage following radiotherapy for breast cancer [J]. Radiother Oncol, 2000, 55(2):179-186.
|
[7] |
Debenham BJ, Hu KS, Harrison LB. Present status and future directions of intraoperative radiotherapy [J]. Lancet Oncol, 2013, 14(11):e457-464.
|
[8] |
Bernstein M. Intraoperative radiation therapy for breast cancer: a patient’s view [J]. Lancet, 2016, 387(10031):1904-1905.
|
[9] |
Piroth MD. Risk-adapted targeted intraoperative radiotherapy versus whole breast irradiation in breast cancer patients [J]. Strahlenther Onkol, 2014, 190(8):767-769.
|
[10] |
刘蕾,李席如,马林,等. 64例乳腺癌保留乳房手术联合术中放射治疗的近期疗效观察[J/CD]. 中华乳腺病杂志(电子版),2010, 4(6):683-691.
|
[11] |
朱见,郑鲁明,庄大勇,等. IntraBeam系统在乳腺癌保乳术中应用的安全性研究[J]. 国际外科学杂志,2015, 42(3):168-170.
|
[12] |
赵惠,汪延明,贺青卿,等. INTRABEAM实施乳腺癌术中放疗系统临床应用观察(附20例报告) [J]. 现代肿瘤医学,2014, 22(12):2972-2974.
|
[13] |
柴凡,赵庆丽,张锋军,等. 乳腺癌保留乳房手术联合术中放射治疗60例近期疗效观察[J/CD]. 中华乳腺病杂志(电子版),2017, 11(1):13-18.
|
[14] |
潘凌霄,郑文博,叶熹罡,等. 术中放疗辅助下早期乳腺癌保乳根治术的临床分析[J]. 中国普通外科杂志,2014, 23(11):1467-1471.
|
[15] |
刘军,黄林平,周伟,等. 术中放疗在早期乳腺癌保乳手术中的应用观察[J]. 中日友好医院学报,2016, 30(3):137-140.
|
[16] |
许鸣,华长江,赵锐. 放射外科手术系统的工作原理及临床应用[J]. 中国医学装备,2011, 8(5):40-42.
|
[17] |
Pan L, Zheng W, Ye X, et al. A novel approach of INTRABEAM intraoperative radiotherapy for nipple-sparing mastectomy with breast reconstruction[J]. Clin Breast Cancer, 2014, 14(6):435-441.
|
[18] |
叶熹罡,潘凌霄,陈伦,等. 术中放疗在乳腺癌保留乳头乳晕复合体乳房再造术中的应用[J]. 重庆医学,2015, 44(8):1109-1111.
|
[19] |
Moradi F, Ung NM, Khandaker MU, et al. Monte Carlo skin dose simulation in intraoperative radiotherapy of breast cancer using spherical applicators [J]. Phys Med Biol,2017, 62(16):6550-6566.
|
[20] |
Schwid M, Donnelly ED, Zhang H. Therapeutic analysis of Intrabeam-based intraoperative radiation therapy in the treatment of unicentric breast cancer lesions utilizing a spherical target volume model [J]. J Appl Clin Med Phys, 2017, 18(5):184-194.
|
[21] |
Saleh Y, Zhang H. Technical note: dosimetric impact of spherical applicator size in Intrabeam™ IORT for treating unicentric breast cancer lesions [J]. Med Phys, 2017, 44(12):6706-6714.
|
[22] |
Petit JY, Veronesi U, Orecchia R, et al. Nipple sparing mastectomy with nipple areola intraoperative radiotherapy: one thousand and one cases of a five years experience at the European institute of oncology of Milan (EIO) [J]. Breast Cancer Res Treat. 2009, 117(2):333-338.
|
[23] |
万明辉,伍锐,潘凌霄,等. 术中放疗在早期乳腺癌保乳治疗中的临床应用[J]. 南通大学学报(医学版),2017, 37(3):203-205.
|
[24] |
Chang DW, te Marvelde L, Chua BH. Prospective study of local control and late radiation toxicity after intraoperative radiation therapy boost for early breast cancer[J]. Int J Radiat Oncol Biol Phys, 2014, 88(1):73-79.
|
[25] |
Intra M, Leonardi C, Luini A, et al. Full-dose intraoperative radiotherapy with electrons in breast surgery: broadening the indications[J]. Arch Surg, 2005, 140(10):936-939.
|
[26] |
Sperk E, Welzel G, Keller A, et al. Late radiation toxicity after intraoperative radiotherapy (IORT) for breast cancer: results from the randomized phase Ⅲ trial TARGIT A [J]. Breast Cancer Res Treat, 2012, 135(1):253-260.
|
[27] |
Welzel G, Boch A, Sperk E, et al. Radiation-related quality of life parameters after targeted intraoperative radiotherapy versus whole breast radiotherapy in patients with breast cancer: results from the randomized phase Ⅲ trial TARGIT-A [J]. Radiat Oncol, 2013, 8:9.
|
[28] |
Veronesi U, Orecchia R, Maisonneuve P, et al. Intraoperative radiotherapy versus external radiotherapy for early breast cancer (ELIOT): a randomised controlled equivalence trial [J]. Lancet Oncol, 2013, 14(13):1269-1277.
|
[29] |
Punglia RS, Saito AM, Neville BA, et al. Impact of interval from breast conserving surgery to radiotherapy on local recurrence in older women with breast cancer: retrospective cohort analysis [J]. BMJ, 2010, 340:c845.
|
[30] |
Coombs NJ, Coombs JM, Vaidya UJ, et al. Environmental and social benefits of the targeted intraoperative radiotherapy for breast cancer: data from UK TARGIT-A trial centres and two UK NHS hospitals offering TARGIT IORT[J]. BMJ Open, 2016, 6(5):e010703.
|
[31] |
朱见,贺青卿,郑鲁明,等. INTRABEAM放疗系统在乳腺癌保乳术中应用研究[J]. 中华内分泌外科杂志,2017, 11(2):97-100.
|
[32] |
Keshtgar MR, Williams NR, Bulsara M,et al. Objective assessment of cosmetic outcome after targeted intraoperative radiotherapy in breast cancer: results from a randomised controlled trial [J]. Breast Cancer Res Treat, 2013, 140(3):519-525.
|
[33] |
王丹,贺青卿,朱见,等. INTRABEAM放疗系统在乳腺癌保乳术中的研究进展[J]. 国际外科学杂志,2018, 45(1):46-49.
|
[34] |
Vanderwalde NA, Jones EL, Kimple RJ, et al. Phase 2 study of pre-excision single-dose intraoperative radiation therapy for early-stage breast cancers: six-year update with application of the ASTRO accelerated partial breast irradiation consensus statement criteria [J]. Cancer, 2013, 119(9):1736-1743.
|
[35] |
Herskind C, Griebel J, Kraus-Tiefenbacher U, et al. Sphere of equivalence--a novel target volume concept for intraoperative radiotherapy using low-energy X rays [J]. Int J Radiat Oncol Biol Phys, 2008, 72(5):1575-1581.
|
[36] |
Wenz F, Welzel G, Blank E, et al. Intraoperative radiotherapy as a boost during breast-conserving surgery using low-kilovoltage X-rays: the first 5 years of experience with a novel approach [J]. Int J Radiat Oncol Biol Phys, 2010, 77(5):1309-1314.
|
[37] |
Kraus-Tiefenbacher U, Scheda A, Steil V, et al. Intraoperative radiotherapy(IORT) for breast cancer uxing the Intrabeam system[J]. Tumori, 2005, 91(4):339-345.
|
[38] |
Vaidya JS, Baum M, Tobias JS, et al. Long-term results of targeted intraoperative radiotherapy(Targit) boost during breast-conserving surgery[J]. Int Radiat Oncol Biol Phys, 2011,81(4):1091-1097.
|
[39] |
Deneve JL, Hoefer RA Jr, Harris EE, et al. Accelerated partial breast irradiation: a review and description of an early North American surgical experience with the intrabeam delivery system [J]. Cancer Control, 2012, 19(4):295-308.
|
[40] |
Belletti B, Vaidya JS, D’Andrea S, et al. Targeted intraoperative radiotherapy impairs the stimulation of breast cancer cell proliferation and invasion caused by surgical wounding [J]. Clin Cancer Res, 2008, 14(5):1325-1332.
|
[41] |
Key S, Miglierini P, Dupré PF, et al. Cosmetic outcome and chronic breast toxicity after intraoperative radiation therapy (IORT) as a single modality or as a boost using the Intrabeam® device: a prospective study[J]. Ann Surg Oncol,2017, 24(9):2547-2555.
|
[42] |
Watson PGF, Bekerat H, Papaconstadopoulos P, et al. An investigation into the INTRABEAM miniature x-ray source dosimetry using ionization chamber and radiochromic film measurements [J]. Med Phys, 2018, 45(9): 4274-4286.
|
[43] |
Sethi A, Emami B, Small W Jr, et al. Intraoperative radiotherapy with INTRABEAM: technical and dosimetric considerations [J]. Front Oncol,2018, 8: 1-10.
|